U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may - Maraviroc - Document - PDFSEARCH.IO

First Page	Meta Content
	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Open Document File Size: 50,74 KB Share Result on Facebook Company Pfizer Inc. / / Facility University of Maryland University College / University Boulevard / The Inn / / MedicalCondition HIV / / Organization Antiviral Drugs Advisory Committee / University of Maryland University College / Division of Antiviral Drug Products office of New Drugs / CENTER FOR DRUG EVALUATION AND RESEARCH / office of New Drugs / U.S. Food and Drug Administration / Division of Antiviral Drug Products / / Person Debra B. Birnkrant / Safety James Goodrich / Poonam Mishra / Paul T. Tran / Scott Proestel / Howard Meyer / Craig W. Hendrix / Microbiology Michael Westby / Efficacy Jayvant Heera / / Position Medical Team Leader DAVP / Director / Medical Officer DAVP / Federal Official / Chair / / SocialTag Medicine Maraviroc Center for Drug Evaluation and Research Antiretroviral drug Pfizer CCR5 New Drug Application Zidovudine CCR5 receptor antagonist Food and Drug Administration

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List